한글목차

급성 케어 증후군 진단 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 45억 9,000만 달러에서 2026년에는 51억 7,000만 달러로, CAGR 12.8%로 성장이 전망되고 있습니다. 지난 수년간의 성장 요인으로는 응급 감염 진단 수요, 병원 중환자실 확충, 감염병 발생 대비 노력, 분자진단 기술 도입, 중환자실 워크플로우 최적화 등을 꼽을 수 있습니다.

급성기 증후군 검사 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 83억 달러에 달하며, CAGR은 12.5%에 달할 전망입니다. 예측 기간의 성장 요인으로는 AI를 활용한 증후군 패널 검사, 긴급 검사 확대, 항균제 적정 사용 프로그램, Point of Care 분자진단 시스템, 팬데믹 대응에 대한 집중을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 신속한 다중 병원체 검출, 응급실에서의 분자 검사, 단일 검체를 통한 다질환 패널, 임상적 판단 지원의 신속화, 진단 결과 보고 시간 단축 등을 꼽을 수 있습니다.

감염성 질환 증가 추세는 급성 케어 증후군 진단 시장의 성장을 가속할 것으로 예측됩니다. 세균, 바이러스, 곰팡이, 기생충 등 유해 미생물에 의한 감염은 사람 간 접촉, 동물, 환경을 통해 전파될 수 있습니다. 인구 증가, 도시화, 국제 이동, 항균제 내성, 기후 변화 등의 요인이 이러한 질병의 발생률 증가에 기여하고 있으며, 효과적인 진단 및 치료 솔루션에 대한 수요를 증가시키고 있습니다. 급성기 증후군 검사는 다중 분자진단 기술을 통해 병원체 및 중복 감염을 확인하는 데 중요한 역할을 하며, 표적화된 치료 방침을 결정할 수 있습니다. 예를 들어 2024년 2월 영국 보건안전청이 보고한 바에 따르면 2024년 4주차 독감 양성률은 전주 14.0%에서 16.6%로 상승했습니다. 인플루엔자 유사 질환(ILI) 환자도 증가하며 전주 10만 명당 7.5명에서 9.8명으로 증가했습니다. 반면, 독감으로 인한 입원 환자 수는 10만 명당 5.12명에서 7.63명으로 증가했습니다. 그 결과, 감염성 질환 증가 추세는 급성기 증후군 검사 시장의 확대를 견인하고 있습니다.

급성기 증후군 검사 시장의 주요 기업은 다중 실시간 중합효소연쇄반응(PCR) 기술의 발전을 활용하여 진단 정확도 향상, 신속한 병원체 검출, 검사실 워크플로우의 효율화, 검사 결과 보고 시간 단축을 위해 노력하고 있습니다. 다중 실시간 PCR은 한 번의 반응으로 여러 병원체 또는 유전자 표적을 동시에 검출 및 정량화하는 첨단 분자진단법으로, 질병 진단의 효율성과 정확성을 향상시킵니다. 2023년 4월, 네덜란드에 본사를 둔 생명공학 기업 QIAGEN N.V.는 일본에서 QIAstat-Dx 증후군 검사 솔루션을 출시했습니다. 본 시스템은 단일 검체에서 20종 이상의 병원체를 검출할 수 있는 SARS-CoV-2 호흡기 패널이 특징입니다. 다중 실시간 PCR 기술을 활용하여 기존 PCR 검사에 비해 최소한의 노력으로 빠른 결과를 제공합니다. 2022년 말까지 전 세계에서 3,500대 이상의 QIAstat-Dx 시스템이 도입되어 호흡기 질환, 소화기 질환, 수막염 관련 질환의 진단을 돕고 있습니다. 100개국 이상에서 사용 가능한 이 시스템은 전 세계 증후군 검사에 대한 접근성 향상에 기여하고 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Acute care syndromic testing is a rapid molecular diagnostic approach that detects multiple pathogens simultaneously from a single patient sample. Primarily used in emergency and critical care settings, it enables quicker diagnosis of infectious diseases, leading to faster treatment decisions, improved patient outcomes, and reduced hospital stays.

The main disease types in the acute care syndromic testing market include respiratory diseases, gastrointestinal diseases, genitourinary diseases, tropical diseases, and others. Respiratory diseases affect the lungs, airways, and respiratory tract, causing symptoms such as coughing, shortness of breath, and fever. Various sample types used for testing include blood, urine, biofluids, stool, swabs, and more. The tests target bacteria, viruses, fungi, and parasites and are utilized in hospitals, clinical and diagnostic laboratories, research and academic institutions, and other healthcare settings.

Tariffs have increased costs of reagents, cartridges, and molecular testing platforms in the acute care syndromic testing market. Respiratory and gastrointestinal panels are most affected, particularly in regions reliant on imported diagnostics. However, tariffs have accelerated local manufacturing and innovation in compact, cost-efficient testing systems.

The acute care syndromic testing market research report is one of a series of new reports from The Business Research Company that provides acute care syndromic testing market statistics, including acute care syndromic testing industry global market size, regional shares, competitors with a acute care syndromic testing market share, detailed acute care syndromic testing market segments, market trends and opportunities, and any further data you may need to thrive in the acute care syndromic testing industry. This acute care syndromic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The acute care syndromic testing market size has grown rapidly in recent years. It will grow from $4.59 billion in 2025 to $5.17 billion in 2026 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to emergency infection diagnosis demand, hospital ICU expansion, outbreak preparedness initiatives, molecular diagnostic adoption, critical care workflow optimization.

The acute care syndromic testing market size is expected to see rapid growth in the next few years. It will grow to $8.3 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to AI-enabled syndromic panels, expansion of emergency testing, antimicrobial stewardship programs, point-of-care molecular systems, pandemic preparedness focus. Major trends in the forecast period include rapid multiplex pathogen detection, emergency department molecular testing, single-sample multi-disease panels, faster clinical decision support, reduced diagnostic turnaround time.

The increasing prevalence of infectious diseases is expected to drive the growth of the acute care syndromic testing market. Infectious diseases, caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, can spread through human contact, animals, or the environment. Factors such as population growth, urbanization, global travel, antimicrobial resistance, and climate change are contributing to the rising incidence of these diseases, increasing the demand for effective diagnostic and treatment solutions. Acute care syndromic testing plays a crucial role in identifying pathogens and co-infections through multiplex molecular diagnostics, allowing for targeted treatment decisions. For example, in February 2024, the UK Health Security Agency reported that in week 4 of 2024, the influenza positivity rate rose to 16.6%, up from 14.0% the previous week. Influenza-like illness (ILI) consultations also increased, reaching 9.8 per 100,000 people compared to 7.5 per 100,000 in the prior week, while influenza hospitalizations climbed from 5.12 to 7.63 per 100,000. Consequently, the growing incidence of infectious diseases is fueling the expansion of the acute care syndromic testing market.

Leading companies in the acute care syndromic testing market are leveraging advancements in multiplex real-time polymerase chain reaction (PCR) technology to enhance diagnostic accuracy, enable rapid pathogen detection, streamline laboratory workflows, and reduce turnaround time. Multiplex real-time PCR is an advanced molecular diagnostic method that simultaneously detects and quantifies multiple pathogens or genetic targets in a single reaction, improving efficiency and accuracy in disease diagnosis. In April 2023, QIAGEN N.V., a Netherlands-based biotechnology company, launched the QIAstat-Dx syndromic testing solution in Japan. This system features a SARS-CoV-2 respiratory panel capable of detecting over 20 pathogens from a single sample. Using multiplex real-time PCR technology, it provides rapid results with minimal labor compared to traditional PCR assays. By the end of 2022, over 3,500 QIAstat-Dx systems had been installed worldwide, aiding in the diagnosis of respiratory, gastrointestinal, and meningitis-related conditions. Available in more than 100 countries, this system is improving global access to syndromic testing.

In May 2023, Applied BioCode, a US-based biotechnology company, partnered with Medline Industries to expand the distribution of the BioCode MDx-3000 System. This collaboration aims to enhance access to diagnostic testing for hospitals and reference laboratories across the U.S. Medline Industries LP, a US-based healthcare company specializing in medical supplies and healthcare services, will support the distribution of Applied BioCode's multiplex diagnostic solutions, further advancing syndromic testing capabilities.

Major companies operating in the acute care syndromic testing market are Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Seegene Inc., bioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Werfen, DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Biocartis NV, Microbiologics Inc., QuantuMDx Group Ltd., Curetis GmbH by OpGen Inc., Genetic Signatures Ltd., Applied BioCode Inc.

North America was the largest region in the acute care syndromic testing market in 2025. The regions covered in the acute care syndromic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the acute care syndromic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The acute care syndromic testing market consists of revenues earned by entities by providing services such as comprehensive pathogen detection, rapid turnaround time, and support for antimicrobial stewardship. The market value includes the value of related goods sold by the service provider or included within the service offering. The acute care syndromic testing market also includes sales of blood collection tubes, or urine containers, PCR and RT-PCR machines, and reader devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acute Care Syndromic Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses acute care syndromic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acute care syndromic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The acute care syndromic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Disease Type: Respiratory Diseases; Gastrointestinal Diseases; Genitourinary Diseases; Tropical Diseases; Other Disease Types
• 2) By Sample Type: Blood; Urine; Biofluids; Stool; Swabs; Other Sample Types
• 3) By Target: Bacteria; Viruses; Fungi; Parasites
• 4) By End User: Hospitals; Clinical And Diagnostic Laboratories; Research And Academic Institutions; Other End Users
• Subsegments:
• 1) By Respiratory Diseases: Influenza; Respiratory Syncytial Virus (RSV); COVID-19; Tuberculosis; Other Respiratory Diseases
• 2) By Gastrointestinal Diseases: Clostridium Difficile Infection; Norovirus; Rotavirus; Salmonella; Other Gastrointestinal Diseases
• 3) By Genitourinary Diseases: Urinary Tract Infections (UTIs); Sexually Transmitted Infections (STIs); Vaginal Infections; Other Genitourinary Diseases
• 4) By Tropical Diseases: Malaria; Dengue; Chikungunya; Zika Virus; Other Tropical Diseases
• 5) By Other Disease Types: Meningitis; Sepsis; Other Emerging Infectious Diseases
• Companies Mentioned: Siemens Healthineers AG; F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Danaher Corporation; Becton Dickinson and Company; Seegene Inc.; bioMerieux SA; Sysmex Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Werfen; DiaSorin S.p.A.; Quidel Corporation; Luminex Corporation; Biocartis NV; Microbiologics Inc.; QuantuMDx Group Ltd.; Curetis GmbH by OpGen Inc.; Genetic Signatures Ltd.; Applied BioCode Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Acute Care Syndromic Testing Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Acute Care Syndromic Testing Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Acute Care Syndromic Testing Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Acute Care Syndromic Testing Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Rapid Multiplex Pathogen Detection
  • 4.2.2 Emergency Department Molecular Testing
  • 4.2.3 Single-Sample Multi-Disease Panels
  • 4.2.4 Faster Clinical Decision Support
  • 4.2.5 Reduced Diagnostic Turnaround Time

5. Acute Care Syndromic Testing Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Emergency Care Units
• 5.3 Clinical Diagnostic Laboratories
• 5.4 Intensive Care Units
• 5.5 Public Health Laboratories

6. Acute Care Syndromic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Acute Care Syndromic Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Acute Care Syndromic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Acute Care Syndromic Testing Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Acute Care Syndromic Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Acute Care Syndromic Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Acute Care Syndromic Testing Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Acute Care Syndromic Testing Market Segmentation

• 9.1. Global Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Respiratory Diseases, Gastrointestinal Diseases, Genitourinary Diseases, Tropical Diseases, Other Disease Types
• 9.2. Global Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Blood, Urine, Biofluids, Stool, Swabs, Other Sample Types
• 9.3. Global Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bacteria, Viruses, Fungi, Parasites
• 9.4. Global Acute Care Syndromic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Clinical And Diagnostic Laboratories, Research And Academic Institutions, Other End Users
• 9.5. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Respiratory Diseases, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Influenza, Respiratory Syncytial Virus (RSV), COVID-19, Tuberculosis, Other Respiratory Diseases
• 9.6. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Gastrointestinal Diseases, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Clostridium Difficile Infection, Norovirus, Rotavirus, Salmonella, Other Gastrointestinal Diseases
• 9.7. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Genitourinary Diseases, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Urinary Tract Infections (UTIs), Sexually Transmitted Infections (STIs), Vaginal Infections, Other Genitourinary Diseases
• 9.8. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Tropical Diseases, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Malaria, Dengue, Chikungunya, Zika Virus, Other Tropical Diseases
• 9.9. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Meningitis, Sepsis, Other Emerging Infectious Diseases

10. Acute Care Syndromic Testing Market Regional And Country Analysis

• 10.1. Global Acute Care Syndromic Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Acute Care Syndromic Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Acute Care Syndromic Testing Market

• 11.1. Asia-Pacific Acute Care Syndromic Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Acute Care Syndromic Testing Market

• 12.1. China Acute Care Syndromic Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Acute Care Syndromic Testing Market

• 13.1. India Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Acute Care Syndromic Testing Market

• 14.1. Japan Acute Care Syndromic Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Acute Care Syndromic Testing Market

• 15.1. Australia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Acute Care Syndromic Testing Market

• 16.1. Indonesia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Acute Care Syndromic Testing Market

• 17.1. South Korea Acute Care Syndromic Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Acute Care Syndromic Testing Market

• 18.1. Taiwan Acute Care Syndromic Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Acute Care Syndromic Testing Market

• 19.1. South East Asia Acute Care Syndromic Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Acute Care Syndromic Testing Market

• 20.1. Western Europe Acute Care Syndromic Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Acute Care Syndromic Testing Market

• 21.1. UK Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Acute Care Syndromic Testing Market

• 22.1. Germany Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Acute Care Syndromic Testing Market

• 23.1. France Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Acute Care Syndromic Testing Market

• 24.1. Italy Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Acute Care Syndromic Testing Market

• 25.1. Spain Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Acute Care Syndromic Testing Market

• 26.1. Eastern Europe Acute Care Syndromic Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Acute Care Syndromic Testing Market

• 27.1. Russia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Acute Care Syndromic Testing Market

• 28.1. North America Acute Care Syndromic Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Acute Care Syndromic Testing Market

• 29.1. USA Acute Care Syndromic Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Acute Care Syndromic Testing Market

• 30.1. Canada Acute Care Syndromic Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Acute Care Syndromic Testing Market

• 31.1. South America Acute Care Syndromic Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Acute Care Syndromic Testing Market

• 32.1. Brazil Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Acute Care Syndromic Testing Market

• 33.1. Middle East Acute Care Syndromic Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Acute Care Syndromic Testing Market

• 34.1. Africa Acute Care Syndromic Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Acute Care Syndromic Testing Market Regulatory and Investment Landscape

36. Acute Care Syndromic Testing Market Competitive Landscape And Company Profiles

• 36.1. Acute Care Syndromic Testing Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Acute Care Syndromic Testing Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Acute Care Syndromic Testing Market Company Profiles
  • 36.3.1. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

37. Acute Care Syndromic Testing Market Other Major And Innovative Companies

• Seegene Inc., bioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Werfen, DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Biocartis NV, Microbiologics Inc., QuantuMDx Group Ltd., Curetis GmbH by OpGen Inc., Genetic Signatures Ltd., Applied BioCode Inc.

38. Global Acute Care Syndromic Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Acute Care Syndromic Testing Market

40. Acute Care Syndromic Testing Market High Potential Countries, Segments and Strategies

• 40.1 Acute Care Syndromic Testing Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Acute Care Syndromic Testing Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Acute Care Syndromic Testing Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer